Discovery and pathogenic characterization of novel monogenic causes of bladder dysfunction.

膀胱功能障碍的新单基因原因的发现和致病特征。

• 批准号: 10381698
• 负责人: Nina Mann
• 金额: $ 16.79万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10381698
• 关键词: Adult; Advisory Committees; Affect; Anatomy; Animal Model; Autonomic nervous system; Behavior; Behavioral; Bladder; Bladder Dysfunction; Boston; Candidate Disease Gene; Child; Childhood; Chronic Kidney Failure; Copy Number Polymorphism; Data; Defect; Development; Development Plans; Disease; End stage renal failure; Ensure; Environment; Etiology; Gene Expression; Genes; Genetic; Genets; Genitourinary system; Genomic approach; Genomics; Grant; Healthcare; Human; Impairment; Individual; International; Kidney; Laboratories; Lead; Life; Lower urinary tract; Mediating; Mentors; Mesenchyme; Metanephric Diverticulum; Methods; Microarray Analysis; Molecular; Muscle Contraction; Muscle relaxation phase; Mutation; Nervous System Physiology; Neurogenic Bladder; Neurologic Deficit; Nicotinic Receptors; Obstruction; Pathogenesis; Pathogenicity; Pathway interactions; Patients; Pediatric Hospitals; Population; Proteins; RNA Splicing; Regulation; Relaxation; Renal Replacement Therapy; Reporting; Research; Research Personnel; Signal Transduction; Smooth Muscle; Specimen; Syndrome; Techniques; Therapeutic; Therapeutic Intervention; Training; Urinary tract; Urine; Urologic Diseases; Urothelium; Validation; Variant; base; care burden; career development; cohort; congenital anomalies of the kidney; diagnostic value; exome; exome sequencing; genetic disorder diagnosis; genetic pedigree; genetic variant; human disease; insight; malformation; medical schools; meetings; nephrogenesis; nerve supply; novel; novel therapeutic intervention; prenatal; prevent; research and development; success; symposium; transcriptome sequencing; transcriptomics; urinary; urinary tract obstruction

PROJECT SUMMARY Title: Discovery and pathogenic characterization of novel monogenic causes of bladder dysfunction Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in childhood. Over 40 monogenic etiologies of CAKUT have been identified, and another 150 genes have been described to cause syndromes in which urinary tract malformations are an integral component. However, the majority of these genes coalesce into pathways that regulate upper urinary tract development, such as metanephric mesenchyme transition and ureteric bud formation. The pathogenesis and genetic regulation of lower urinary tract disease remain poorly understood. Recently, through the use of whole exome sequencing, I identified mutations in the α3-subunit of the nicotinic acetylcholine receptor, CHRNA3, as a novel cause of bladder dysfunction with secondary CAKUT. This is one of just eight known monogenic causes of congenital bladder dysfunction, and, uniquely, is a gene that regulates autonomic nervous system function. I hypothesize that additional monogenic causes of lower urinary tract disease can be identified through the use of whole exome sequencing, and additionally, that these genes will coalesce upon pathways that regulate urothelial signaling, detrusor contraction, and bladder innervation. The aims of the proposed research are twofold: (1) to apply both a candidate gene and unbiased analysis strategy to whole exome sequencing data in order to discover novel monogenic causes of bladder dysfunction and (2) to apply an integrated genomic approach using whole exome and whole transcriptome sequencing to an international cohort of children with CAKUT. Accomplishment of the proposed research above will provide additional insight into the pathomechanisms that govern bladder development and function, and, ultimately, could lead to novel therapeutic strategies for children with bladder dysfunction. In addition, validation of a method for urinary transcriptome sequencing can help to overcome current limitations in whole exome sequencing in the identification and interpretation of splice-altering genetic variants. This K08 application encompasses a comprehensive career development plan to not only ensure progress and success in carrying out the proposed research, but also to facilitate my transition to an independent investigator. It encompasses regular meetings with my mentor and advisory committee, research and career development seminars, courses in genomics and transcriptomics, and participation at national and international conferences. The research will be conducted in the rich academic environment at Boston Children's Hospital and Harvard Medical School, which provides an ideal environment for further training and career development.

项目概要 标题：膀胱功能障碍的新单基因原因的发现和致病特征 肾脏和泌尿道先天性异常 (CAKUT) 是慢性肾病的最常见原因 已确定超过 40 种 CAKUT 的单基因病因，以及另外 150 种。 基因已被描述为引起以尿路畸形为一个组成部分的综合征 然而，这些基因中的大多数结合成调节上尿路的途径。 发育，例如后肾间充质转变和输尿管芽形成。 最近，人们对下尿路疾病的基因调控仍知之甚少。 通过外显子组测序，我发现烟碱乙酰胆碱受体 CHRNA3 的 α3 亚基发生突变，如下所示 继发性 CAKUT 膀胱功能障碍的新原因 这是已知的八种单基因原因之一。 先天性膀胱功能障碍的原因，并且独特的是调节自主神经系统的基因 我认为可以确定下尿路疾病的其他单基因原因。 通过使用全外显子组测序，此外，这些基因将结合在 调节尿路上皮信号传导、逼尿肌收缩和膀胱神经支配的途径。 拟议研究的目的有两个：（1）应用候选基因和无偏分析 全外显子组测序数据的策略，以发现膀胱功能障碍的新单基因原因 (2) 应用整合基因组方法，利用全外显子组和全转录组测序 完成上述拟议研究将提供国际 CAKUT 儿童队列。 对控制膀胱发育和功能的病理机制有更多的了解，并最终， 可能会为患有膀胱功能障碍的儿童带来新的治疗策略。 尿转录组测序方法有助于克服目前全外显子组的局限性 测序在剪接改变遗传变异的鉴定和解释中的应用。 该 K08 申请包含全面的职业发展计划，不仅确保进步 并成功开展拟议的研究，同时也促进我向独立过渡 它包括与我的导师和咨询委员会、研究和职业的定期会议。 发展研讨会、基因组学和转录组学课程以及参加国家和 该研究将在波士顿丰富的学术环境中进行。 儿童医院和哈佛医学院，为进一步培训和学习提供了理想的环境 职业发展。